BOEING CO/THE (BCO.DE) Stock Fundamental Analysis
FRA:BCO - Deutsche Boerse Ag - US0970231058 - Common Stock - Currency: EUR
We assign a fundamental rating of 1 out of 10 to BCO. BCO was compared to 43 industry peers in the Aerospace & Defense industry. BCO may be in some trouble as it scores bad on both profitability and health. BCO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BCO had negative earnings in the past year.
BCO had a negative operating cash flow in the past year.
In the past 5 years BCO always reported negative net income.
In multiple years BCO reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.45%, BCO is doing worse than 86.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.45% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for BCO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
BCO has more shares outstanding than it did 1 year ago.
BCO has more shares outstanding than it did 5 years ago.
BCO has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.12, we must say that BCO is in the distress zone and has some risk of bankruptcy.
BCO's Altman-Z score of 1.12 is on the low side compared to the rest of the industry. BCO is outperformed by 81.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.12 |
ROIC/WACCN/A
WACC9.38%
2.3 Liquidity
BCO has a Current Ratio of 1.23. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
BCO has a Current ratio (1.23) which is in line with its industry peers.
BCO has a Quick Ratio of 1.23. This is a bad value and indicates that BCO is not financially healthy enough and could expect problems in meeting its short term obligations.
BCO has a worse Quick ratio (0.37) than 95.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for BCO have decreased strongly by -247.36% in the last year.
The Revenue has decreased by -9.15% in the past year.
BCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
3.2 Future
BCO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.96% yearly.
The Revenue is expected to grow by 13.88% on average over the next years. This is quite good.
EPS Next Y91.71%
EPS Next 2Y47.77%
EPS Next 3Y32.65%
EPS Next 5Y18.96%
Revenue Next Year23.81%
Revenue Next 2Y20.52%
Revenue Next 3Y17.14%
Revenue Next 5Y13.88%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 54.05 indicates a quite expensive valuation of BCO.
81.40% of the companies in the same industry are cheaper than BCO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BCO is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 54.05 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCO's earnings are expected to grow with 32.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.77%
EPS Next 3Y32.65%
5. Dividend
5.1 Amount
No dividends for BCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BCO (5/28/2025, 7:00:00 PM)
178.06
-0.28 (-0.16%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap134.26B
Analysts78.92
Price Target178.19 (0.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.94%
Min EPS beat(2)-91.07%
Max EPS beat(2)63.2%
EPS beat(4)2
Avg EPS beat(4)-16.75%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)5
Avg EPS beat(12)-793.15%
EPS beat(16)6
Avg EPS beat(16)-758.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.7%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.79%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-2.69%
Revenue beat(8)2
Avg Revenue beat(8)-2.15%
Revenue beat(12)2
Avg Revenue beat(12)-3.63%
Revenue beat(16)2
Avg Revenue beat(16)-5.09%
PT rev (1m)-5.96%
PT rev (3m)-1.74%
EPS NQ rev (1m)-39.86%
EPS NQ rev (3m)-37.04%
EPS NY rev (1m)9.99%
EPS NY rev (3m)-8.5%
Revenue NQ rev (1m)-2.33%
Revenue NQ rev (3m)-1.79%
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 54.05 | ||
| P/S | 2.2 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-17.37
EYN/A
EPS(NY)3.29
Fwd EY1.85%
FCF(TTM)-14.9
FCFYN/A
OCF(TTM)-12.07
OCFYN/A
SpS81.1
BVpS-3.88
TBVpS-15.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.45% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 130.38% | ||
| Cap/Sales | 3.49% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 1.12 |
F-Score3
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
EPS Next Y91.71%
EPS Next 2Y47.77%
EPS Next 3Y32.65%
EPS Next 5Y18.96%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
Revenue Next Year23.81%
Revenue Next 2Y20.52%
Revenue Next 3Y17.14%
Revenue Next 5Y13.88%
EBIT growth 1Y-1098.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.79%
EBIT Next 3Y49.92%
EBIT Next 5Y32.37%
FCF growth 1Y-351.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-261.22%
OCF growth 3YN/A
OCF growth 5YN/A